Drug Shortage Report for PEGALAX

Last updated on 2022-03-10 History
Report ID 155275
Drug Identification Number 02328232
Brand name PEGALAX
Common or Proper name Polyethylene Glycol 3350 Powder for oral solution
Company Name ARALEZ PHARMACEUTICALS CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) POLYETHYLENE GLYCOL 3350
Strength(s) 100%
Dosage form(s) POWDER FOR SOLUTION
Route of administration ORAL ORAL
Packaging size carton of 14 sachets
ATC code A06AD
ATC description DRUGS FOR CONSTIPATION
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2022-02-18
Actual start date 2022-02-18
Estimated end date 2022-03-09
Actual end date 2022-03-09
Shortage status Resolved
Updated date 2022-03-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6733 MISSISSAUGA RD
MISSISSAUGA, ONTARIO
CANADA L5N 6J5
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2022-03-10 English Compare
v8 2022-03-09 French Compare
v7 2022-03-09 English Compare
v6 2022-03-09 English Compare
v5 2022-03-03 French Compare
v4 2022-03-03 English Compare
v3 2022-02-19 English Compare
v2 2022-02-18 French Compare
v1 2022-02-18 English Compare

Showing 1 to 9 of 9